治疗高血压的新药成本——澳大利亚的经验
The cost of new drugs in the treatment of hypertension--the Australian experience.
作者信息
Louis W J
机构信息
Austin Hospital, Heidelberg, Victoria, Australia.
出版信息
Cardiovasc Drugs Ther. 1989 Dec;3(6):825-7. doi: 10.1007/BF01869566.
PMID:2518653
Abstract
The treatment of hypertension by costly new drugs such as the angiotensin converting enzyme inhibitors, means that careful monitoring of health care expenditure is essential. If drugs like simvastatin come to be widely used, costs will mount even more. New drugs cannot be used indiscriminately.
摘要
使用血管紧张素转换酶抑制剂等昂贵新药治疗高血压，这意味着必须仔细监测医疗保健支出。如果像辛伐他汀这样的药物被广泛使用，成本将进一步增加。新药不能被随意使用。
Zotero 插件